NVS Novartis AG
- Stocks
- Healthcare
- NYSE: NVS
Price (delayed)
$116.84
Market cap
$226.19B
P/E Ratio
16.91
Dividend/share
$3.87
EPS
$6.91
Enterprise value
$252.17B
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world
Highlights
The gross profit rose by 15% year-on-year and by 4.5% since the previous quarter
Novartis AG's revenue has increased by 13% YoY and by 3.7% QoQ
The company's net income fell by 16% YoY but it rose by 6% QoQ
The quick ratio is down by 15% year-on-year but it is up by 2% since the previous quarter
The company's debt rose by 13% YoY and by 4.4% QoQ
Key stats
What are the main financial stats of NVS
Market
Valuations
Earnings
Shares outstanding
1.94B
Market cap
$226.19B
Enterprise value
$252.17B
Price to earnings (P/E)
16.91
Price to book (P/B)
5.45
Price to sales (P/S)
4.12
EV/EBIT
15.08
EV/EBITDA
9.1
EV/Sales
4.57
Revenue
$55.19B
Gross profit
$42.08B
Operating income
$16.68B
Net income
$13.65B
EBIT
$16.72B
EBITDA
$27.72B
Free cash flow
$19.38B
Per share
Balance sheet
Liquidity
EPS
$6.91
EPS diluted
$6.85
Free cash flow per share
$9.95
Book value per share
$21.43
Revenue per share
$28.33
TBVPS
$25.46
Total assets
$104.4B
Total liabilities
$62.34B
Debt
$32.64B
Equity
$41.99B
Working capital
-$5.78B
Debt to equity
0.78
Current ratio
0.82
Quick ratio
0.51
Net debt/EBITDA
0.94
Margins
Efficiency
Dividend
EBITDA margin
50.2%
Gross margin
76.2%
Net margin
24.7%
Operating margin
30.2%
Return on assets
13.3%
Return on equity
32.6%
Return on invested capital
40.1%
Return on capital employed
23%
Return on sales
30.3%
Dividend yield
3.31%
DPS
$3.87
Payout ratio
56%
NVS stock price
How has the Novartis AG stock price performed over time
Intraday
0.79%
1 week
1.34%
1 month
-3.98%
1 year
5.24%
YTD
20.07%
QTD
-3.45%
Financial performance
How have Novartis AG's revenue and profit performed over time
Revenue
$55.19B
Gross profit
$42.08B
Operating income
$16.68B
Net income
$13.65B
Gross margin
76.2%
Net margin
24.7%
NVS's operating income is up by 42% year-on-year and by 5% since the previous quarter
NVS's operating margin is up by 26% year-on-year
The company's net margin fell by 25% YoY but it rose by 2.1% QoQ
The company's net income fell by 16% YoY but it rose by 6% QoQ
Price vs fundamentals
How does NVS's price correlate with its fundamentals
Growth
What is Novartis AG's growth rate over time
Valuation
What is Novartis AG stock price valuation
P/E
16.91
P/B
5.45
P/S
4.12
EV/EBIT
15.08
EV/EBITDA
9.1
EV/Sales
4.57
The company's EPS fell by 12% YoY but it rose by 7% QoQ
The stock's P/E is 9% less than its 5-year quarterly average of 18.5 but 4.4% more than its last 4 quarters average of 16.2
NVS's P/B is 33% above its 5-year quarterly average of 4.1 and 2.8% above its last 4 quarters average of 5.3
The company's equity rose by 9% QoQ
Novartis AG's revenue has increased by 13% YoY and by 3.7% QoQ
The P/S is 4.2% less than the 5-year quarterly average of 4.3
Efficiency
How efficient is Novartis AG business performance
The ROIC has declined by 24% year-on-year
The company's return on sales fell by 17% YoY
Novartis AG's ROA has decreased by 17% YoY but it has increased by 3.9% from the previous quarter
NVS's ROE is down by 16% YoY but it is up by 6% QoQ
Dividends
What is NVS's dividend history
DPS
$3.87
Dividend yield
3.31%
Payout ratio
56%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Novartis AG financials performed over time
NVS's total assets is 67% greater than its total liabilities
The quick ratio is down by 15% year-on-year but it is up by 2% since the previous quarter
Novartis AG's current ratio has decreased by 12% YoY but it has increased by 3.8% QoQ
The company's debt is 22% lower than its equity
The debt to equity has grown by 13% YoY but it has contracted by 3.7% from the previous quarter
The company's debt rose by 13% YoY and by 4.4% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.